Camlin Fine Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 14.4 pts more than Nifty Microcap 250 and 14.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Camlin Fine Sciences has filed its audited financial results for the quarter and year ended March 31, 2025 with the stock exchange. The announcement itself only confirms the submission of results and does not include the detailed numbers, segment breakdown, or auditor's remarks in this notice. Investors should refer to the full results PDF and auditor's report for actual revenue, profit, margin, and cash flow figures.
This is a routine compliance filing — it makes the FY25 numbers officially public but does not itself move the stock. The actual price reaction will depend on whether the detailed results show a beat or miss versus expectations, especially on revenue growth, margins, and debt levels given the company's specialty chemicals profile.